Biogen Inc. 13D and 13G filings for Sangamo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-16 6:40 pm Sale |
2024-08-14 | 13G | Sangamo Therapeutics, Inc. SGMO |
BIOGEN IDEC INC. BIIB |
3,250,000 1.600% |
-11,402,466 (-77.82%) |
Filing |
| 2024-02-12 7:11 pm Sale |
2023-12-31 | 13G | Sangamo Therapeutics, Inc. SGMO |
BIOGEN IDEC INC. BIIB |
14,652,466 8.260% |
-9,767,691 (-40.00%) |
Filing |